An emerging surgical technique added to the standard anterior cruciate ligament (ACL) reconstruction in high-risk adolescent athletes resulted in [...]
RESTEM, a leading cell-based therapeutics company, announced today it has received approval from the U.S. Food and Drug Administration (FDA) for a [...]